In the BioHarmony Drug Report Database

"Preview" Icon

Florbetapir (18f)

Amyvid (florbetapir f 18) is a small molecule pharmaceutical. Florbetapir f 18 was first approved as Amyvid on 2012-04-06. It has been approved in Europe to treat radionuclide imaging. The pharmaceutical is active against amyloid-beta precursor protein. Amyvid’s patent is valid until 2027-04-30 (FDA).

 

Trade Name

 

Amyvid
 

Common Name

 

florbetapir f 18
 

ChEMBL ID

 

CHEMBL1774461
 

Indication

 

radionuclide imaging
 

Drug Class

 

Image (chem structure or protein)

Florbetapir (18f) structure rendering